NSE filing, NSE: GML. Summary written from the filing by ALFA Finder's alert engine.
Galaxy Medicare Ltd: key numbers
- Share price
- ₹18.00
- Market cap
- ₹27.31 Cr
- Revenue (annual)
- ₹40.00 Cr
- Net profit (annual)
- ₹3.42 Cr
- P/E (TTM)
- 8.0×Sector 52.0×
- Promoter holding
- 73.36%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Galaxy Medicare Ltd
All →Galaxy Medicare Other Announcement
Galaxy Medicare, listed on NSE SME, filed a non-applicability certificate for the Reg 27(2) corporate governance report for the quarter ended 30 September 2026. The exemption, as an SME-platform entity, carries no financial or business impact.
Galaxy Medicare Annual General Meeting
Galaxy Medicare Limited held its 34th Annual General Meeting on September 28, 2026. Shareholders approved all agenda items, including the adoption of financial statements and dividend declaration.
Galaxy Medicare Dividend
Galaxy Medicare Limited has fixed September 11, 2026, as the record date for determining shareholder entitlement to the final dividend for the 2025-26 financial year.
Galaxy Medicare Other Announcement
Galaxy Medicare Limited announced the re-appointment of Mr. Purnendu Bhusan Mohanty as Internal Auditor. The appointment is for a term of 12 months.
Galaxy Medicare Annual General Meeting
Galaxy Medicare approved the FY 2025-26 Annual Report and the notice for its 34th AGM, scheduled for September 28, 2026.
Galaxy Medicare Results Correction
Galaxy Medicare Limited submitted a Working Capital Certificate and corrected a clerical error regarding paid-up equity share capital in its XBRL filing.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.